Searle & CO. Has $1.77 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Searle & CO. increased its holdings in CVS Health Co. (NYSE:CVS) by 1.1% in the 3rd quarter, Holdings Channel reports. The fund owned 28,130 shares of the pharmacy operator’s stock after purchasing an additional 300 shares during the period. Searle & CO.’s holdings in CVS Health were worth $1,769,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CVS. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth $31,000. Crewe Advisors LLC acquired a new position in shares of CVS Health during the 1st quarter valued at about $40,000. Retirement Group LLC lifted its holdings in CVS Health by 54.3% in the 1st quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock worth $41,000 after purchasing an additional 182 shares during the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health in the third quarter worth $33,000. Finally, First Community Trust NA grew its stake in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CVS shares. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Evercore ISI raised their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Truist Financial raised their price objective on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research note on Friday, October 11th. Finally, Wells Fargo & Company boosted their price objective on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $74.89.

CVS Health Price Performance

Shares of CVS Health stock traded up $0.12 during trading on Wednesday, reaching $56.97. The company’s stock had a trading volume of 3,593,324 shares, compared to its average volume of 11,218,813. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The stock has a 50-day moving average price of $59.87 and a two-hundred day moving average price of $60.19. The stock has a market capitalization of $71.52 billion, a P/E ratio of 9.99, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 EPS. As a group, sell-side analysts anticipate that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. CVS Health’s payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.